{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:33:59Z","timestamp":1789187639588,"version":"build-2803163510"},"reference-count":17,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dan Med J"],"abstract":"<jats:p>INTRODUCTION. The demand for procedural sedation in the emergency department (ED) has risen. This study aims to 1) investigate the safety of remimazolam as analgosedation, 2) evaluate amnesia and the quality of sedation and 3) determine whether the sedation was successful and effectively managed pain for procedures in the ED.\n\nMETHODS. This prospective clinical cohort study was performed by registered nurse anaesthetists in the ED at Aalborg University Hospital from February to May 2024. Outcome measures were 1) adverse effects of remimazolam, proportion of patients reporting 2) adequate sedation or amnesia post-procedure and 3) adequate pain or anxiety relief.\n\nRESULTS. A total of 68 patients (median age 59, 58% female) were sedated by remimazolam with a median dose of 7.5 mg. Most patients (97% (n = 66)) had no or mild respiratory problems during sedation. Two patients had transient severe respiratory problems following sedation. Both patients had received large doses of opioids before remimazolam sedation. Patient satisfaction was 97% based on reports of procedural amnesia or satisfaction with sedation and pain control. Almost all (89%) joint reductions were successfully performed. In over half of patients who would have otherwise required general anaesthesia in an operating room (57%, n = 20\/35), sedation with remimazolam was sufficient to perform the procedure in the ED.\n\nCONCLUSIONS. The use of remimazolam in the ED was a safe and effective sedative treatment with high patient satisfaction levels.\n\nFUNDING. None.\n\nTRIAL REGISTRATION. Not relevant.<\/jats:p>","DOI":"10.61409\/a08240562","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T09:54:31Z","timestamp":1764237271000},"page":"1-10","source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness and safety of remimazolam sedation in the emergency department"],"prefix":"10.61409","author":[{"given":"Sofus","family":"Andreassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Lund","family":"Krarup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Kamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis M\u00f8ller","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Krogh-Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibe Maria Laden","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorte","family":"Melgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"40208","published-online":{"date-parts":[[2025,11]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Chawla N, Boateng A, Deshpande R. Procedural sedation in the ICU and emergency department. Curr Opin Anaesthesiol. 2017;30(4):507-512. https:\/\/doi.org\/10.1097\/ACO.0000000000000487","DOI":"10.1097\/ACO.0000000000000487"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Godwin SA, Burton JH, Gerardo CJ, et al. Clinical policy: procedural sedation and analgesia in the emergency department. Ann Emerg Med. 2014;63(2):247-258.e18. https:\/\/doi.org\/10.1016\/j.annemergmed.2013.10.015","DOI":"10.1016\/j.annemergmed.2013.10.015"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Pastis NJ, Yarmus LB, Schippers F, et al. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Chest. 2019;155(1):137-146. https:\/\/doi.org\/10.1016\/j.chest.2018.09.015","DOI":"10.1016\/j.chest.2018.09.015"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Rex DK, Bhandari R, Desta T, et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2018;88(3):427-437.e6. https:\/\/doi.org\/10.1016\/j.gie.2018.04.2351","DOI":"10.1016\/j.gie.2018.04.2351"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Matsuda Y, Karino M, Kanno T. Relationship between the functional oral intake scale (FOIS) and the self-efficacy scale among cancer patients: a cross-sectional study. Healthcare (Basel). 2020;8(3):269. https:\/\/doi.org\/10.3390\/healthcare8030269","DOI":"10.3390\/healthcare8030269"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Shi W, Cheng Y, He H, et al. Efficacy and safety of the remimazolam-alfentanil combination for sedation during gastroscopy: a randomized, double-blind, single-center controlled trial. Clin Ther. 2022;44(11):1506-1518. https:\/\/doi.org\/10.1016\/j.clinthera.2022.09.014","DOI":"10.1016\/j.clinthera.2022.09.014"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Chang Y, Huang YT, Chi KY, Huang YT. Remimazolam versus propofol for procedural sedation: a meta-analysis of randomized controlled trials. PeerJ. 2023;11:e15495. https:\/\/doi.org\/10.7717\/peerj.15495","DOI":"10.7717\/peerj.15495"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Tang Y, Yang X, Yu Y, et al. Remimazolam versus traditional sedatives for procedural sedation: a systematic review and meta-analysis of efficacy and safety outcomes. Minerva Anestesiol. 2022;88(11):939-949. https:\/\/doi.org\/10.23736\/S0375-9393.22.16631-9","DOI":"10.23736\/S0375-9393.22.16631-9"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Barends CRM, Absalom AR, Struys MMRF. Drug selection for ambulatory procedural sedation. Curr Opin Anaesthesiol. 2018;31(6):673-678. https:\/\/doi.org\/10.1097\/ACO.0000000000000652","DOI":"10.1097\/ACO.0000000000000652"},{"key":"ref9","unstructured":"Kragh-Kr\u00e6mer K, Lambert PH. Preoperative airway assessment. Aalborg University Hospital, 2021. https:\/\/pri.rn.dk\/document\/AALBORGUH-905462050-1882"},{"key":"ref10","unstructured":"Ejstrud P. Sedation of patients with remimazolam without the involvement of anaesthetic personnel. Aalborg University Hospital, 2022. https:\/\/pri.rn.dk\/Sider\/34629.aspx"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"van Vliet R, Breedveld L, Heutinck AAJ, et al. Procedural sedation by advanced practice providers in the emergency medical service in the Netherlands: a retrospective study. Scand J Trauma Resusc Emerg Med. 2024;32(1):39. https:\/\/doi.org\/10.1186\/s13049-024-01207-z","DOI":"10.1186\/s13049-024-01207-z"},{"key":"ref14","unstructured":"Chen S, Wang J, Xu X, et al. The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: a multicentered, randomized, positive-controlled, phase III clinical trial. Am J Transl Res. 2020;12(8):4594-4603"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Masui K. Remimazolam: its clinical pharmacology and evolving role in anesthesia and sedation practice. Curr Opin Anaesthesiol. 2024;37(4):344-351. https:\/\/doi.org\/10.1097\/ACO.0000000000001384","DOI":"10.1097\/ACO.0000000000001384"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Sneyd JR. Remimazolam - current status, opportunities and challenges. APS. 2023;1:25. https:\/\/doi.org\/10.1007\/s44254-023-00021-7","DOI":"10.1007\/s44254-023-00021-7"}],"container-title":["Danish Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T14:54:29Z","timestamp":1765378469000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/dmj\/A08240562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":17,"URL":"https:\/\/doi.org\/10.61409\/a08240562","relation":{},"ISSN":["2245-1919"],"issn-type":[{"value":"2245-1919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}